The purpose of this study was to use an accelerometer to measure daily walking performance in patients with chronic heart failure (CHF) to investigate if this parameter is a determinant of New York Heart Association class and indicative of maximal and functional exercise capacity.; Fifty patients with CHF were instructed to wear an accelerometer for 7 consecutive days while going about their daily business. Maximal and functional exercise capacity was assessed by cardiopulmonary (VO(2peak)) and 6-minute walk testing, respectively.; Patients in New York Heart Association I, II, and III reached an average total walking time (TWT) of 160.6 +/- 35.8 minutes, 133.9 +/- 59.0 minutes, and 76.1 +/- 22.5 minutes per day of which 19%, 19%, and 9% whe...
Introduction: Patients with heart failure (HF) are now a priority group for cardiac rehabilitation (...
Assessment of habitual physical activity (PA) in patients with heart failure.; This study included 5...
AIMS:Patients with heart failure often display a distinct pattern of walking characterized by short ...
The purpose of this study was to use an accelerometer to measure daily walking performance in patien...
Background: Exercise capacity and daily activity are key outcomes for older, frail heart failure pat...
Distance walked in the 6-minute walk test (6MWT) is an important prognostic parameter used clinicall...
Background: In-depth analyses of the measurement properties of the 6-minute walk test (6MWT) in pati...
OBJECTIVE: The 6-minute walk test is an way of assessing exercise capacity and predicting survival i...
BACKGROUND: Few studies report objective accelerometer-measured daily physical activity levels in pa...
Objective: To investigate the influence of gait parameters including step length and walking speed d...
Various walking tests, such as the six-minute walk test (6MWT), are effective tools for assessing fu...
The six-minute walk test (6MWT) highly correlates with results of bicycle ergometry and treadmill as...
Background: Physical activity is the only nonpharmacological therapy that is proven to be effective ...
Introduction: Patients with heart failure (HF) are now a priority group for cardiac rehabilitation (...
Assessment of habitual physical activity (PA) in patients with heart failure.; This study included 5...
AIMS:Patients with heart failure often display a distinct pattern of walking characterized by short ...
The purpose of this study was to use an accelerometer to measure daily walking performance in patien...
Background: Exercise capacity and daily activity are key outcomes for older, frail heart failure pat...
Distance walked in the 6-minute walk test (6MWT) is an important prognostic parameter used clinicall...
Background: In-depth analyses of the measurement properties of the 6-minute walk test (6MWT) in pati...
OBJECTIVE: The 6-minute walk test is an way of assessing exercise capacity and predicting survival i...
BACKGROUND: Few studies report objective accelerometer-measured daily physical activity levels in pa...
Objective: To investigate the influence of gait parameters including step length and walking speed d...
Various walking tests, such as the six-minute walk test (6MWT), are effective tools for assessing fu...
The six-minute walk test (6MWT) highly correlates with results of bicycle ergometry and treadmill as...
Background: Physical activity is the only nonpharmacological therapy that is proven to be effective ...
Introduction: Patients with heart failure (HF) are now a priority group for cardiac rehabilitation (...
Assessment of habitual physical activity (PA) in patients with heart failure.; This study included 5...
AIMS:Patients with heart failure often display a distinct pattern of walking characterized by short ...